Plasmid DNA Manufacturing Market (By Application: Gene Therapy, Vaccinology; By Disease: Infectious Disease, Cancer, Genetic Disorder: Research Institute , Biotech Companies; By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Tables Of Content:

Chapter 1. Industry Overview of Plasmid DNA Manufacturing
1.1 Definition and Scope
   1.1.1 Definition of Plasmid DNA Manufacturing
   1.1.2 Market Segmentation
1.2 Summary
   1.2.1 Market Snapshot
1.3 Global Plasmid DNA Manufacturing Market By Application
   1.3.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Application (2015-2026)
   1.3.2 Gene Therapy
   1.3.3 Vaccinology
1.4 Global Plasmid DNA Manufacturing Market By Disease
   1.4.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
   1.4.2 Infectious Disease
   1.4.3 Genetic Disorders
   1.4.4 Cancer
1.5 Global Plasmid DNA Manufacturing Market By End Use
   1.5.1 Global Plasmid DNA Manufacturing Market Revenue and Growth Rate Comparison By End Use (2015-2026)
   1.5.2 Research Institutes
   1.5.3 Biotech Companies
1.6 Global Plasmid DNA Manufacturing Market by Regions
   1.6.1 Global Plasmid DNA Manufacturing Market Size and Growth Rate Comparison by Regions (2015-2026)
   1.6.2 North America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
   1.6.3 Europe Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
   1.6.4 Asia-Pacific Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
   1.6.5 Latin America Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)
   1.6.6 Middle East & Africa Plasmid DNA Manufacturing Market Revenue And Growth Rate (2015-2026)

Chapter 2. Market Dynamics and Competition Analysis
2.1 Market Drivers
2.2 Restraints and Challenges
2.3 Growth Opportunities
2.4 Porter’s Five Forces Analysis
   2.4.1 Low Bargaining Power of Suppliers
   2.4.2 Medium Bargaining Power of Buyers
   2.4.3 High Threat of Substitute
   2.4.4 Low Threat of New Entrants
   2.4.5 High Degree of Competition
2.5 Value Chain Analysis
2.6 Cost structure Analysis
   2.6.1 Raw Material and Suppliers
   2.6.2 Proportion of Manufacturing Cost Structure
     2.6.2.1 Raw Material
     2.6.2.2 Labor Cost
     2.6.2.3 Manufacturing Expense
2.7 Regulatory Compliance
2.8 Competitive Landscape, 2018
   2.8.1 Player Positioning Analysis
   2.8.2 Key Strategies Adopted By Leading Players

Chapter 3. Manufacturing Plant Analysis
3.1 Revenue and Commercial Date of Global Plasmid DNA Manufacturing Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Plasmid DNA Manufacturing Major Manufacturers in 2018

Chapter 4. Plasmid DNA Manufacturing Market By Application
4.1 Global Plasmid DNA Manufacturing Revenue by Application
4.2 Gene Therapy
   4.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
   4.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$ Million)
4.3 Vaccinology
   4.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
   4.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$ Million)

Chapter 5. Plasmid DNA Manufacturing Market By Disease
5.1 Global Plasmid DNA Manufacturing Revenue by Disease
5.2 Infectious Disease
   5.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
   5.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
5.3 Genetic Disorders
   5.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
   5.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
5.4 Cancer
   5.4.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
   5.4.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)

Chapter 6. Plasmid DNA Manufacturing Market By End Use
6.1 Global Plasmid DNA Manufacturing Revenue by End Use
6.2 Research Institutes
   6.2.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
   6.2.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)
6.3 Biotech Companies
   6.3.1 Market Revenue and Growth Rate, 2015 - 2026 (US$Mn)
   6.3.2 Market Revenue and Forecast, By Region, 2015 - 2026 (US$Mn)

Chapter 7. North America Plasmid DNA Manufacturing Market By Country
7.1 North America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
7.2 North America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
7.3 U.S.
   7.3.1 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   7.3.2 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   7.3.3 U.S. Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
7.4 Canada
   7.4.1 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   7.4.2 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   7.4.3 Canada Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 8. Europe Plasmid DNA Manufacturing Market By Country (8)
8.1 Europe Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
8.2 Europe Plasmid DNA Manufacturing Market Revenue Share, By Country, 2018 (%)
8.3 UK
   8.3.1 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   8.3.2 UK Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   8.3.3 UK Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.4 Germany
   8.4.1 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   8.4.2 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   8.4.3 Germany Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.5 France
   8.5.1 France Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   8.5.2 France Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   8.5.3 France Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.6 Spain
   8.6.1 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   8.6.2 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   8.6.3 Spain Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.7 Italy
   8.7.1 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   8.7.2 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   8.7.3 Italy Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
8.8 Rest of Europe
   8.8.1 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   8.8.2 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   8.8.3 Rest of Europe Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 9. Asia-Pacific Plasmid DNA Manufacturing Market By Country
9.1 Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
9.2 Asia-Pacific Plasmid DNA Manufacturing Market Revenue Share Comparison, By Country, 2015 & 2026 (%)
9.3 China
   9.3.1 China Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   9.3.2 China Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   9.3.3 China Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.4 Japan
   9.4.1 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   9.4.2 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   9.4.3 Japan Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.5 India
   9.5.1 India Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   9.5.2 India Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   9.5.3 India Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.6 Australia
   9.6.1 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   9.6.2 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   9.6.3 Australia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.7 South Korea
   9.7.1 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   9.7.2 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   9.7.3 South Korea Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
9.8 Rest of Asia-Pacific
   9.8.1 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   9.8.2 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   9.8.3 Rest of Asia-Pacific Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 10. Latin America Plasmid DNA Manufacturing Market By Country
10.1 Latin America Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
10.2 Latin America Plasmid DNA Manufacturing Market Revenue Share, by Country, 2018 (%)
10.3 Brazil
   10.3.1 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   10.3.2 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   10.3.3 Brazil Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
10.4 Mexico
   10.4.1 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   10.4.2 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   10.4.3 Mexico Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
10.5 Rest of Latin America
   10.5.1 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   10.5.2 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   10.5.3 Rest of Latin America Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 11. Middle East & Africa Plasmid DNA Manufacturing Market By Country
11.1 Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Growth Rate, 2015 - 2026 (US$ Million)
11.2 Middle East & Africa Plasmid DNA Manufacturing Market Revenue Share Comparison, By Countries, 2018 (%)
11.3 Saudi Arabia
   11.3.1 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   11.3.2 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   11.3.3 Saudi Arabia Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
11.4 UAE
   11.4.1 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   11.4.2 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   11.4.3 UAE Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)
11.5 Rest of Middle East & Africa
   11.5.1 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Application, 2015 - 2026 (US$ Million)
   11.5.2 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By Disease, 2015 - 2026 (US$ Million)
   11.5.3 Rest of Middle East & Africa Plasmid DNA Manufacturing Market Revenue and Forecast By End Use, 2015 - 2026 (US$ Million)

Chapter 12. Major Manufacturers Analysis of Plasmid DNA
12.1 Cobra Biologics Limited
   12.1.1 Business Overview
   12.1.2 Company Profile
   12.1.3 Cobra Biologics Limited 2018 Financial Analysis
   12.1.4 Cobra Biologics Limited 2018 Plasmid DNA Business Region Distribution Analysis
   12.1.5 Product Segment
   12.1.6 Marketing Strategy and Recent Development
12.2 Novasep Inc.
   12.2.1 Business Overview
   12.2.2 Company Profile
   12.2.3 Novasep Inc. 2018 Financial Analysis
   12.2.4 Novasep Inc. 2018 Plasmid DNA Business Region Distribution Analysis
   12.2.5 Product Segment
   12.2.6 Marketing Strategy and Recent Development
12.3 Spark Therapeutics, Inc.
   12.3.1 Business Overview
   12.3.2 Company Profile
   12.3.3 Spark Therapeutics, Inc. 2018 Financial Analysis
   12.3.4 Spark Therapeutics, Inc. 2018 Plasmid DNA Business Region Distribution Analysis
   12.3.5 Product Segment
   12.3.6 Marketing Strategy and Recent Development
12.4 FUJIFILM Diosynth Biotechnologies Inc.
   12.4.1 Business Overview
   12.4.2 Company Profile
   12.4.3 FUJIFILM Diosynth Biotechnologies Inc. 2018 Financial Analysis
   12.4.4 FUJIFILM Diosynth Biotechnologies Inc. 2018 Plasmid DNA Business Region Distribution Analysis
   12.4.5 Product Segment
   12.4.6 Marketing Strategy and Recent Development
12.5 Cell and Gene Therapy Catapult
   12.5.1 Business Overview
   12.5.2 Company Profile
   12.5.3 Cell and Gene Therapy Catapult 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
   12.5.4 Cell and Gene Therapy Catapult 2018 Plasmid DNA Business Region Distribution Analysis
   12.5.5 Product Segment
   12.5.6 Marketing Strategy and Recent Development
12.6 Kaneka Eurogentec S.A (KANEKA)
   12.6.1 Business Overview
   12.6.2 Company Profile
   12.6.3 Kaneka Eurogentec S.A 2018 Plasmid DNA Sales, Ex-factory Price, Revenue, Gross Margin Analysis
   12.6.4 Kaneka Eurogentec S.A 2018 Plasmid DNA Business Region Distribution Analysis
   12.6.5 Product Segment
   12.6.6 Marketing Strategy and Recent Development
12.7 UniQure N.V.
   12.7.1 Business Overview
   12.7.2 Company Profile
   12.7.3 uniQure N.V. Financial Analysis, 2019
   12.7.4 uniQure N.V Plasmid DNA Business Region Distribution Analysis, 2019
   12.7.5 Product Segment
   12.7.6 Marketing Strategy and Recent Development
12.8 Lonza
   12.8.1 Business Overview
   12.8.2 Company Profile
   12.8.3 Lonza Financial Analysis, 2018
   12.8.4 Lonza Plasmid DNA Business Region Distribution Analysis, 2018
   12.8.5 Product Segment
   12.8.6 Marketing Strategy and Recent Development
12.9 Merk KgaA
   12.9.1 Business Overview
   12.9.2 Company Profile
   12.9.3 Merk KgaA Financial Analysis, 2018
   12.9.4 Merk KgaA Plasmid DNA Business Region Distribution Analysis, 2018
   12.9.5 Product Segment
   12.9.6 Marketing Strategy and Recent Development

Chapter 13. Research Approach
13.1 Methodology
   13.1.1 Research Programs/Design
   13.1.2 Market Size Estimation
   13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
   13.2.1 Secondary Sources
   13.2.2 Primary Sources


Cart Summary